116545 ⎘
Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2); Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1) Alpha-L-fucosidase (3.2.1.51)
FEED ADDITIVE COMPOSITIONS AND METHODS FOR USING THE SAME
#2FUCOSIDASE MUTANTS AND THE USE THEREOF
#3GLYCOSIDE HYDOLASES AND THEIR USE IN PREVENTING AND/OR TREATING A PATHOGENIC INFECTION IN AN ANIMAL
#4USING FUCOSIDASE TO CONTROL AFUCOSYLATION LEVEL OF GLYCOSYLATED PROTEINS
#5ANTI-INFLAMMATORY, NON-FUCOSYLATED IMMUNOGLOBULIN PREPARATION AND PRODUCTION METHOD THEREFOR
#6COMPOSITIONS AND METHODS FOR PRODUCING POLYPEPTIDES WITH A MODIFIED GLYCOSYLATION PATTERN IN PLANT CELLS
#7USE OF ENZYME THAT CLEAVES BOTH ALPHA- AND BETA-1,4-GLYCOSIDIC BONDS
#8Anti-CD20 glycoantibodies and uses thereof
#9GLYCOSIDE HYDOLASES AND THEIR USE IN PREVENTING AND/OR TREATING A PATHOGENIC INFECTION IN AN ANIMAL
#10Fusion protein for remodeling antibody glycoform
#11COMPOSITIONS AND METHODS RELATING TO UNIVERSAL GLYCOFORMS FOR ENHANCED ANTIBODY EFFICACY
#12NOVEL FUNGAL FUCOSIDASES AND THEIR USE IN PREVENTING AND/OR TREATING A PATHOGENIC INFECTION IN AN ANIMAL
#13Compositions and methods for producing polypeptides with a modified glycosylation pattern in plant cells
#14SELECTIVE GLYCOSIDASE REGIMEN FOR IMMUNE PROGRAMMING AND TREATMENT OF CANCER
#15COMPOSITIONS AND METHODS RELATING TO UNIVERSAL GLYCOFORMS FOR ENHANCED ANTIBODY EFFICACY
#16Methods for modifying human antibodies by glycan engineering
#17Glycoside hydrolases and their use in preventing and/or treating a pathogenic infection in an animal
#18Anti-HER2 glycoantibodies and uses thereof
#19Cleavage of Fucose in N-Glycans
#20COMPOSITIONS AND METHODS FOR PRODUCING POLYPEPTIDES WITH A MODIFIED GLYCOSYLATION PATTERN IN PLANT CELLS
#21Methods for producing recombinant glycoproteins with modified glycosylation
#22Compositions and methods relating to universal glycoforms for enhanced antibody efficacy
#23Fermentative production of oligosaccharides
#24Fucosidase from bacteroides and methods using the same
#25SELECTIVE GLYCOSIDASE REGIMEN FOR IMMUNE PROGRAMMING AND TREATMENT OF CANCER
#26Anti-HER2 glycoantibodies and uses thereof
#27Anti-TNF-alpha glycoantibodies and uses thereof
#28Compositions and methods relating to universal glycoforms for enhanced antibody efficacy
#29Cellulose and/or hemicelluloses degrading enzymes from and uses thereof
#30Methods for producing recombinant glycoproteins with modified glycosylation
#31Enzymes for inhibiting growth of biofilms and degrading same
#32Pharmaceutical composition for treating lysosomal storage disease
#33Bifidobacterial gene sequences and their use
#34Methods for modifying human antibodies by glycan engineering
#35Bifidobacterial gene sequences and their use
#36METHOD FOR REDUCING FUCOSE CONTENTS OF RECOMBINANT PROTEINS
#37Enzyme for decomposition of sulfated fucan derived from sea cucumber
#38Sulfated fucan